PRF Technologies PRFX
NASDAQ PRFX
$0.93 -0.03 (-3.23%)
At close: Sep 22, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Cash from Operations (2020 - 2024)

PRF Technologies' (PRFX) quarterly Cash from Operations came in at $3.5 million in Q2 2024, up 276.24% on a YoY basis from $938241.8 in Q3 2023, and up 195.53% quarter-over-quarter from -$3.7 million in Q1 2024.

Analysis

PRF Technologies (PRFX) Cash from Operations (2020 - 2024) Analysis & Trends

PRF Technologies (PRFX) has reported Cash from Operations for 5 consecutive years, with $3.5 million the latest figure, recorded in Q2 2024.

  • For the quarter ending Q2 2024, Cash from Operations rose 276.24% year-over-year to $3.5 million; the trailing twelve-month figure through Jun 2024 stood at -$2.9 million (up 62.55% YoY), and the FY2025 full-year result was -$4.0 million, up 68.66% from the prior year.
  • Cash from Operations improved to $3.5 million in Q2 2024 per PRFX's latest filing, from -$3.7 million in the prior quarter.
  • Across five years, Cash from Operations topped out at $3.5 million in Q2 2024 and bottomed at -$3.7 million in Q1 2024.
  • Historically, Cash from Operations has averaged -$1.2 million across 5 years, with a median of -$1.6 million in 2022.
  • The sharpest annual moves came in 2021 and 2024: Cash from Operations slumped 1530.0% in 2021, then jumped 276.24% in 2024.
  • Over 5 years, Cash from Operations stood at -$2.0 million in 2020, then rose by 12.46% to -$1.8 million in 2021, then plunged by 61.94% to -$2.9 million in 2022, then jumped by 45.89% to -$1.6 million in 2023, then soared by 327.45% to $3.5 million in 2024.
  • According to Business Quant data, Cash from Operations over the past three periods registered $3.5 million, -$3.7 million, and -$1.6 million for Q2 2024, Q1 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn 411.00 Mn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn 381.80 Mn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn -9.79 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn -21.24 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn 670.00 Mn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn 56.67 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn -19.79 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn 51.32 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn -
10 PRF Technologies 622,054.07 -10.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 3.53 Mn
Mar 31, 2024 -3.70 Mn
Dec 31, 2023 -1.55 Mn
Sep 30, 2023 -1.17 Mn
Jun 30, 2023 -2.00 Mn
Mar 31, 2023 -1.95 Mn
Dec 31, 2022 -2.87 Mn
Sep 30, 2022 -892,000.00
Jun 30, 2022 -1.59 Mn
Mar 31, 2022 -1.11 Mn
Dec 31, 2021 -1.77 Mn
Sep 30, 2021 -1.36 Mn
Jun 30, 2021 -1.63 Mn
Mar 31, 2021 -1.79 Mn
Dec 31, 2020 -2.02 Mn
Sep 30, 2020 -219,000.00
Jun 30, 2020 -100,000.00
Mar 31, 2020 -215,000.00
API Access

PRF Technologies Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=PRFX&period=max&api_key=YOUR_API_KEY